FIELD: medicine.
SUBSTANCE: invention relates to medicine and is a method for determining mitochondrial dysfunction in patients with non-alcoholic fatty liver disease (NAFLD), which consists of a clinical and laboratory research, characterized in that DNA is isolated from leukocytes of the venous blood of a patient with NAFLD, followed by a polymerase chain reaction using standard primer pairs, followed by determination of length of end sections of peripheral blood leukocyte chromosomes, and at the obtained values of this indicator above, the reference ones determine mitochondrial dysfunctions in patients with NAFLD, in particular, for hepatology and clinical laboratory diagnostics.
EFFECT: proposed invention allows to improve the accuracy, sensitivity and specificity of the method for determining mitochondrial dysfunction in patients with non-alcoholic fatty liver disease (NAFLD), to reduce the time for its implementation.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF HEPATOTROPHIC THERAPY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2015 |
|
RU2595827C1 |
| METHOD FOR DETERMINATION OF FEASIBILITY OF IMMUNOLOGICAL STUDY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE | 2015 |
|
RU2617236C1 |
| METHOD FOR MODELLING NON-ALCOHOLIC FATTY LIVER DISEASE BY DIET RICH IN FRUCTOSE | 2019 |
|
RU2728418C1 |
| METHOD FOR PREDICTION OF PROGRESSIVE CLINICAL COURSE OF EARLY FORMS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2020 |
|
RU2768466C1 |
| METHOD OF TREATING PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS ON BACKGROUND OF METABOLIC SYNDROME | 2015 |
|
RU2595815C1 |
| METHOD FOR PREDICTING NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765848C1 |
| METHOD OF SCREENING STUDY OF RISK OF DEVELOPING LIVER DAMAGE OF DIFFERENT ORIGINS | 2017 |
|
RU2675015C1 |
| METHOD OF EARLY DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 |
|
RU2798723C1 |
| METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765847C1 |
| METHOD OF TREATING NONALCOHOLIC FATTY LIVER DISEASE WITH USE OF PENTOXIFYLLINE AMPLI-PULSE PHORESIS | 2014 |
|
RU2548775C1 |
